PCN15 CAPECITABINE VS. BOLUS 5-FU/LV AS ADJUVANT THERAPY FOR PATIENTS WITH DUKES' C COLON CANCER- PHARMACOECONOMIC EVALUATION OF X-ACT TRIAL– DATA FROM CZECH PERSPECTIVE
Nov 1, 2006, 00:00
10.1016/S1098-3015(10)63445-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)63445-6/fulltext
Title :
PCN15 CAPECITABINE VS. BOLUS 5-FU/LV AS ADJUVANT THERAPY FOR PATIENTS WITH DUKES' C COLON CANCER- PHARMACOECONOMIC EVALUATION OF X-ACT TRIAL– DATA FROM CZECH PERSPECTIVE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63445-6&doi=10.1016/S1098-3015(10)63445-6
First page :
Section Title :
Open access? :
No
Section Order :
298